MIFEPRISTONE REGIMENS BIBLIOGRAPHY

1. Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. Bmj. Aug 28 1993;307(6903):532-537.
Link to PubMed

2. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. Bjog. Apr 2000;107(4):524-530.
Link to PubMed

3. Medical abortion at 57 to 63 days' gestation with a lower dose of mifepristone and gemeprost. A randomized controlled trial. Acta Obstet Gynecol Scand. May 2001;80(5):447-451.
Link to PubMed

4. Lowering the doses of mifepristone and gameprost for early abortion: a randomised controlled trial. World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation. Bjog. Jul 2001;108(7):738-742.
Link to PubMed

5. Ashima T, Vinita A, Shalini R. Early medical abortion: a new regimen up to 49 days' gestation. Aust N Z J Obstet Gynaecol. Apr 2005;45(2):137-139.
Link to PubMed

6. Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod. Oct 1998;13(1O):2962-2965.
Link to PDF

7. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Bjog. Nov 2002;109(11):1281-1289.
Link to PubMed

8. Baird DT. Medical abortion in the first trimester. Best Pract Res Clin Obstet Gynaecol. Apr 2002;16(2):221-236.
Link to PubMed

9. Bartley J, Brown A, Elton R, Baird DT. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation. Hum Reprod. Oct 2001;16(10):2098-2102.
Link to PDF

10. Beal MW, Simmonds K. Clinical uses of mifepristone: an update for women's health practitioners. J Midwifery Womens Health. Nov-Dec 2002;47(6):451-460.
Link to PubMed

11. Creinin MD, Shore E, Balasubramanian S, Harwood B. The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion. Contraception. Jan 2005;71(1):26-30.
Link to PubMed

12. Ellertson C, Simonds W, Winikoff B, Springer K, Bagchi D. Providing mifepristone-misoprostol medical abortion: the view from the clinic. J Am Med Womens Assoc. Spring 1999;54(2):91-96.
Link to PubMed

13. Ellertson C, Waldman SN. The mifepristone-misoprostol regimen for early medical abortion. Curr Womens Health Rep. Dec 2001;1(3):184-190.
Link to PubMed

14. Ferriman A. Medical abortion still not available in most countries. Bmj. Oct 23 1999;319(7217):1091.
Link to PubMed

15. Fiala C, Winikoff B, Helstrom L, Hellborg M, Gemzell-Danielsson K. Acceptability of home-use of misoprostol in medical abortion. Contraception. Nov 2004;70(5):387-392.
Link to PubMed

16. Fielding SL, Schaff EA, Nam NY. Clinicians' perception of sonogram indication for mifepristone abortion up to 63 days. Contraception. Jul 2002;66(1):27-31.
Link to PubMed

17. Gemperli MP, Stewart FH, Phillips KA, Sakowski J, Van Bebber S, Bergthold L. A qualitative study of insurers' coverage for mifepristone-induced abortion. Manag Care Interface. Mar 2005;18(3):26-30, 32.
Link to PubMed

18. Goldberg JR, Plescia MG, Anastasio GD. Mifepristone (RU 486): current knowledge and future prospects. Arch Fam Med. May-Jun 1998;7(3):219-222.
Link to PDF

19. Grimes DA. Medical abortion in early pregnancy: a review of the evidence. Obstet Gynecol. May 1997;89(5 Pt 1):790-796.
Link to PubMed

20. Guest J, Chien P, Thomson M, Kosseim ML. Randomised controlled trial comparing efficacy of same day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36- to 48-hour protocol. Bjog. Oct 2005;112(10):1457.
Link to PubMed

21. Hamoda H, Ashok PW, Flett GM, Templeton A. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation. Bjog. Aug 2005;112(8):1102-1108.
Link to PubMed

22. Hamoda H, Critchley HO, Paterson K, Guthrie K, Rodger M, Penney GC. The acceptability of home medical abortion to women in UK settings. Bjog. Jun 2005;112(6):781-785.
Link to PubMed

23. Harper C, Ellertson C, Winikoff B. Could American women use mifepristone-misoprostol pills safely with less medical supervision? Contraception. Feb 2002;65(2):133-142.
Link to PubMed

24. Harper C, Winikoff B, Ellertson C, Coyaji K. Blood loss with mifepristone--misoprostol abortion: measures from a trial in China, Cuba and India. Int J Gynaecol Obstet. Oct 1998;63(1):39-49.
Link to PubMed

25. Harvey SM, Beckman LJ, Satre SJ. Experiences and satisfaction with providing methotrexate-induced abortions among US providers. J Am Med Womens Assoc. 2000;55(3 Suppl):161-163.
Link to PubMed

26. Hausknecht R. Mifepristone and misoprostol for early medical abortion: 18 months experience in the United States. Contraception. Jun 2003;67(6):463-465.
Link to PubMed

27. Hedley A, Ellertson C, Trussell J, et al. Accounting for time: insights from a life-table analysis of the efficacy of medical abortion. Am J Obstet Gynecol. Dec 2004;191(6):1928-1933.
Link to PubMed

28. Hedley A, Trussell J, Turner AN, et al. Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion. Contraception. Feb 2004;69(2):157-163.
Link to PubMed

29. Henshaw RC, Naji SA, Russell IT, Templeton AA. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. Bmj. Sep 18 1993;307(6906):714-717.
Link to PubMed

30. Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Hum Reprod. Nov 1994;9(11):2167-2172.
Link to PubMed

31. Holmgren K. Women's evaluation of three early abortion methods. Acta Obstet Gynecol Scand. Dec 1992;71(8):616-623.
Link to PubMed

32. Honkanen H, Piaggio G, Hertzen H, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. Bjog. Jul 2004;111(7):715-725.
Link to PubMed

33. Howie FL, Henshaw RC, Naji SA, Russell IT, Templeton AA. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. Br J Obstet Gynaecol. Jul 1997;104(7):829-833.
Link to PubMed

34. Jain JK, Dutton C, Harwood B, Meckstroth KR, Mishell DR, Jr. A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod. Jun 2002;17(6):1477-1482.
Link to PDF

35. Jones RK, Henshaw SK. Mifepristone for early medical abortion: experiences in France, Great Britain and Sweden. Perspect Sex Reprod Health. May-Jun 2002;34(3):154-161.
Link to PDF

36. Kahn JG, Becker BJ, MacIsaa L, et al. The efficacy of medical abortion: a meta-analysis. Contraception. Jan 2000;61(1):29-40.
Link to PubMed

37. Knudsen UB. First trimester abortion with mifepristone and vaginal misoprostol. Contraception. May 2001;63(5):247-250.
Link to PubMed

38. Koenig JD, Tapias MP, Hoff T, Stewart FH. Are US health professionals likely to prescribe mifepristone or methotrexate? J Am Med Womens Assoc. 2000;55(3 Suppl):155-160.
Link to PubMed

39. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2004(2):CD002855.
Link to PubMed

40. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2004(1):CD002855.
Link to PubMed

41. Liao AH, Han XJ, Wu SY, Xiao D, Xiong CL, Wu XR. Randomized, double-blind, controlled trial of mifepristone in capsule versus tablet form followed by misoprostol for early medical abortion. Eur J Obstet Gynecol Reprod Biol. Oct 15 2004;116(2):211-216.
Link to PubMed

42. Mackenzie SJ, Yeo S. Pregnancy interruption using mifepristone (RU-486). A new choice for women in the USA. J Nurse Midwifery. Mar-Apr 1997;42(2):86-90.
Link to PubMed

43. Mamers PM, Lavelle AL, Evans AJ, Bell SM, Rusden JR, Healy DL. Women's satisfaction with medical abortion with RU486. Med J Aust. Sep 15 1997;167(6):316-317.
Link to Full Text

44. Martin CW, Brown AH, Baird DT. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary. Contraception. Aug 1998;58(2):99-103.
Link to PubMed

45. McKinley C, Thong KJ, Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod. Sep 1993;8(9):1502-1505.
Link to PubMed

46. Meckstroth KR, Darney PD. Prostaglandins for first-trimester termination. Best Pract Res Clin Obstet Gynaecol. Oct 2003;17(5):745-763.
Link to PubMed

47. Mittal S, Agarwal S, Kumar S, Batra A. Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion. Indian J Med Res. Aug 2005;122(2):132-136.
Link to PDF

48. Murthy AS, Creinin MD, Harwood B, Schreiber C. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation. Contraception. May 2005;71(5):333-336.
Link to PubMed

49. Newhall EP, Winikoff B. Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions. Am J Obstet Gynecol. Aug 2000;183(2 Suppl):S44-53.
Link to PubMed

50. Norman JE, Thong KJ, Rodger MW, Baird DT. Medical abortion in women of less than or equal to 56 days amenorrhoea: a comparison between gemeprost (a PGE1 analogue) alone and mifepristone and gemeprost. Br J Obstet Gynaecol. Jul 1992;99(7):601-606.
Link to PubMed

51. Paul M, Schaff E, Nichols M. The roles of clinical assessment, human chorionic gonadotropin assays, and ultrasonography in medical abortion practice. Am J Obstet Gynecol. Aug 2000;183(2 Suppl):S34-43.
Link to PubMed

52. Phelps RH, Schaff EA, Fielding SL. Mifepristone abortion in minors. Contraception. Dec 2001;64(6):339-343.
Link to PubMed

53. Prasad RN, Choolani M, Roy A, Ratnam SS. Blood loss in termination of early pregnancy with mifepristone and gemeprost. Aust N Z J Obstet Gynaecol. Aug 1995;35(3):329-331.
Link to PubMed

54. Rademakers J, Koster E, Jansen-van Hees AC, Willems F. Medical abortion as an alternative to vacuum aspiration: first experiences with the 'abortion pill' in The Netherlands. Eur J Contracept Reprod Health Care. Dec 2001;6(4):185-191.
Link to PubMed

55. Ravn P, Rasmussen A, Knudsen UB, Kristiansen FV. An outpatient regimen of combined oral mifepristone 400 mg and misoprostol 400 microg for first-trimester legal medical abortion. Acta Obstet Gynecol Scand. Nov 2005;84(11):1098-1102.
Link to PubMed

56. Rossi B, Creinin MD, Meyn LA. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. Contraception. Oct 2004;70(4):313-317.
Link to PubMed

57. Sang GW, Weng LJ, Shao QX, et al. Termination of early pregnancy by two regimens of mifepristone with misoprostol and mifepristone with PG05--a multicentre randomized clinical trial in China. Contraception. Dec 1994;50(6):501-510.
Link to PubMed

58. Schaff EA, DiCenzo R, Fielding SL. Comparison of misoprostol plasma concentrations following buccal and sublingual administration. Contraception. Jan 2005;71(1):22-25.
Link to PubMed

59. Schaff EA, Eisinger SH, Stadalius LS. Weighing The Options In Medical Abortion. Medscape Womens Health. Sep 1997;2(9):1.
Link to PubMed

60. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception. Jan 1999;59(1):1-6.
Link to PubMed

61. Schaff EA, Fielding SL. A comparison of the Abortion Rights Mobilization and Population Council trials. J Am Med Womens Assoc. 2000;55(3 Suppl):137-140.
Link to PubMed

62. Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception. Jan 2000;61(1):41-46.
Link to PubMed

63. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion. Contraception. Aug 2001;64(2):81-85.
Link to PubMed

64. Schaff EA, Fielding SL, Westhoff C. Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy. Contraception. Oct 2002;66(4):247-250.
Link to PubMed

65. Schaff EA, Fielding SL, Westhoff C, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. Jama. Oct 18 2000;284(15):1948-1953.
Link to PubMed

66. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract. Apr 1997;44(4):353-360.
Link to PubMed

67. Schreiber CA, Creinin MD, Harwood B, Murthy AS. A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days. Contraception. Jun 2005;71(6):447-450.
Link to PubMed

68. Shannon CS, Winikoff B, Hausknecht R, et al. Multicenter trial of a simplified mifepristone medical abortion regimen. Obstet Gynecol. Feb 2005;105(2):345-351.
Link to PubMed

69. Simonds W, Ellertson C, Springer K, Winikoff B. Abortion, revised: participants in the U.S. clinical trials evaluate mifepristone. Soc Sci Med. May 1998;46(10):1313-1323.
Link to PubMed

70. Slade P, Heke S, Fletcher J, Stewart P. A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care. Br J Obstet Gynaecol. Dec 1998;105(12):1288-1295.
Link to PubMed

71. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. Apr 30 1998;338(18):1241-1247.
Link to PubMed

72. Stubblefield PG, Carr-Ellis S, Borgatta L. Methods for induced abortion. Obstet Gynecol. Jul 2004;104(1):174-185.
Link to PubMed

73. Swahn ML, Bygdeman M. Medical methods to terminate early pregnancy. Baillieres Clin Obstet Gynaecol. Jun 1990;4(2):293-306.
Link to PubMed      

74. Tang OS, Chan CC, Ng EH, Lee SW, Ho PC. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod. Nov 2003;18(11):2315-2318.
Link to PDF

75. Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol for medical abortion. Contraception. Nov 2001;64(5):315-317.
Link to PubMed

76. Tang OS, Lee SW, Ho PC. A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone. Hum Reprod. Nov 2002;17(11):2865-2868.
Link to PDF

77. Tang OS, Miao BY, Lee SW, Ho PC. Pilot study on the use of repeated doses of sublingual misoprostol in termination of pregnancy up to 12 weeks gestation: efficacy and acceptability. Hum Reprod. Mar 2002;17(3):654-658.
Link to PDF

78. Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. Feb 2002;17(2):332-336.
Link to PDF

79. Tang OS, Xu J, Cheng L, Lee SW, Ho PC. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation. Hum Reprod. Jul 2002;17(7):1738-1740.
Link to PDF

80. Tang OS, Xu J, Cheng L, Lee SW, Ho PC. The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: a randomized placebo controlled trial. Hum Reprod. Jan 2002;17(1):99-102.
Link to PDF

81. Thong KJ, Brooks AN, Baird DT. Dose and time dependent rise of plasma cortisol following administration of mifepristone in early pregnancy. Br J Obstet Gynaecol. Sep 1993;100(9):880-882.
Link to PubMed

82. Trussell J, Ellertson C. Estimating the efficacy of medical abortion. Contraception. Sep 1999;60(3):119-135.
Link to PubMed

83. Ulmann A. The development of mifepristone: a pharmaceutical drama in three acts. J Am Med Womens Assoc. 2000;55(3 Suppl):117-120.
Link to PubMed

84. von Hertzen H, Honkanen H, Piaggio G, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. Bjog. Sep 2003;110(9):808-818.
Link to PubMed

85. Wiebe ER. Misoprostol administration in medical abortion. A comparison of three regimens. J Reprod Med. Feb 2001;46(2):125-129.
Link to PubMed

86. Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plann Perspect. Jul-Aug 1995;27(4):142-148, 185.
Link to Full Text

87. Winikoff B, Coyaji K, Cabezas E, et al. Studying the acceptability and feasibility of medical abortion. Law Med Health Care. Fall 1992;20(3):195-198.
Link to PubMed

88. Winikoff B, Ellertson C, Elul B, Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group. Arch Fam Med. Jul-Aug 1998;7(4):360-366.
Link to PDF

89. Winikoff B, Sivin I, Coyaji KJ, et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol. Feb 1997;176(2):431-437.
Link to PubMed

90. Xu J, Chen H, Ma T, Wu X. Termination of early pregnancy in the scarred uterus with mifepristone and misoprostol. Int J Gynaecol Obstet. Mar 2001;72(3):245-251.
Link to PubMed

Privacy Policy
This site is not intended to provide legal, medical or other professional advice.
It is not a substitute for consultation with a healthcare provider or for independent judgment by healthcare providers or other professionals regarding individual conditions and situations.